Table 3.

The significance of the association of Hcy with versus without individual clinical manifestations and pathergy reaction.

		Hcy levels (μmol/L) in patients with		Hcy levels (μmol/L) in patients without
Manifestations	No. of Patients	Median	(Range)	Median	(Range)	P-values
Oral ulcer	31	18.03	(8–39.3)	14.28	(6.4–29)	P = .003*
Genital ulcer	23	18.1	(11.9–38.1)	14.28	(6.4–39.3)	P = .005*
Ocular lesion	18	21.59	(14–39.3)	14.15	(6.4–38)	P = .00*
Vascular lesion	37	19	(11.9–39.3)	13.75	(6.4–26)	P = .00*
Arthritis/arthralgia	25	16	(6.4–39.3)	15	(8–38.1)	P = .99
EN/PPE	31	16	(8.1–38.1)	14.88	(6.4–39.3)	P = .306
(+) pathergy	35	17.2	(7.9–38.1)	14	(6.4–39.3)	P = .007*

P* < .05 by Mann-Whitney U test (statistically significant with versus without clinical manifestations).

Data are presented as median values and their individual ranges within parentheses.